ÓÐÕâÑùһȺÈË£¬´Ó³öÉúÆð¾ÍÎÞ·¨ÏñÕý³£º¢×ÓÒ»ÑùËÁÒâ±¼ÅÜÍæË££¬²»¾Òâ¼äµÄС¿ÄÅö¶¼¿ÉÄÜÈÃËûÃÇѪÁ÷²»Ö¹£¬»»¿ÅÑÀ³ÝÒ²¿ÉÄÜΣ¼°ÉúÃü......ËûÃÇÊDz£Á§Ò»°ã¡°Ò×Ë顱µÄº¢×Ó£¬ÐèÒª¸ü¶àµÄ¹ØÐĺͺǻ¤£¬ËûÃǾÍÊÇѪÓѲ¡»¼Õß¡£
ÿÄêµÄ4ÔÂ17ÈÕÊÇÊÀ½çѪÓѲ¡ÈÕ¡£ÈÃk8¿·¢¹ú¼ÊÒ»ÆðÁ˽âѪÓѲ¡£¬¹ØעѪÓѲ¡µÄ¿Æѧ·ÀÖΡ£
ʲôÊÇѪÓѲ¡£¿
ѪÓѲ¡ÊÇÒ»×éÒÅ´«ÐÔ³öѪÐÔ¼²²¡£¬ÆäÌØÕ÷ÔÚÓÚ»¼ÕßÌåÄÚȱ·¦Ä³Ð©¹Ø¼üµÄÄýѪÒò×Ó£¬µ¼ÖÂѪҺÎÞ·¨Õý³£Äý¹Ì£¬´Ó¶øÒý·¢Ò»ÏµÁгöѪ֢״¡£
¸ù¾ÝËùȱ·¦µÄÄýѪÒò×ÓÖÖÀ࣬ѪÓѲ¡Ö÷Òª·ÖΪÒÔÏÂÁ½ÖÖÀàÐÍ£º
ѪÓѲ¡A£¨¾µäÐÍѪÓѲ¡£©£ºÕâÊÇ×î³£¼ûµÄÀàÐÍ£¬Õ¼ËùÓÐѪÓѲ¡²¡ÀýµÄÔ¼80%-85%¡£ËüÊÇÓÉÄýѪÒò×Ó VIII£¨Òò×Ó°Ë£©µÄȱ·¦»ò¹¦ÄÜÕÏ°ÒýÆðµÄ¡£
ѪÓѲ¡B£¨ÒÒÐÍѪÓѲ¡£©£ºÕâÀàѪÓѲ¡Õ¼Ê£ÓಡÀýµÄÔ¼15%-20%£¬ÓÉÄýѪÒò×Ó IX£¨Òò×Ӿţ©µÄȱ·¦»ò¹¦ÄÜÕÏ°ÒýÆðµÄ¡£
ѪÓѲ¡»¼Õß×î´óµÄÌصã¾ÍÊÇ´ÓС¾Í´æÔÚ³öѪÇãÏò£¬ÔÚÊÜÉË»ò½ÓÊÜÊÖÊõºó£¬ÇáÕß¹ý¶ÈÓÙѪ£¬ÖØÕßѪÁ÷²»Ö¹£»´ËÍ⣬ѪÓѲ¡»¼Õß³£ÓпڱdzöѪºÍ賦µÀ³öѪµÄÖ¢×´£¬»¹¿ÉÄÜÒòΪ·´¸´µÄ¹Ø½Ú³öѪ¶øÌÛÍ´ÄÑÈÌÉõÖÁ¹Ø½ÚËðÉË¡¢»ûÐζøµ¼Ö²м²¡£
ѪÓѲ¡ÎÞ·¨¸ùÖΣ¬ÐèÖÕÉúÕÕ»¤
Òź¶µÄÊÇ£¬ÁÙ´²ÉÏÖÁ½ñÉÐÎÞ³¹µ×ÖÎÓúѪÓѲ¡µÄ·½·¨£¬»¼Õß´æÔÚÖÕÉíÕÕ»¤µÄÐèÇó¡£È«Çòҽѧ½ç³ÖÐøÖÂÁ¦ÓÚ¸ÄÉÆѪÓѲ¡µÄÖÎÁÆÊÖ¶ÎÓëÌáÉý»¼ÕßµÄÉú»îÖÊÁ¿£¬µ«Ïֽ׶εĺËÐIJßÂÔÈÔ¼¯ÖÐÔÚ¶àѧ¿ÆÐ×÷µÄ×ÛºÏÕÕ»¤ÉÏ¡£
ѪÓѲ¡»¼ÕßµÄÖÎÁƺÍÕÕ»¤ÓÐÒÔϹؼüÒªµã£º
Ìæ´úÒò×ÓÖÎÁÆ
ÕâÊÇѪÓѲ¡Ä¿Ç°µÄÖ÷ÒªÖÎÁÆ·½·¨£¬°üÀ¨Êä×¢ÏàÓ¦µÄÄýѪÒò×ÓÀ´²¹³ä»¼ÕßµÄÄýѪ¹¦ÄÜ£¬ÒÔ¼õÉÙ»ò×èÖ¹³öѪʼþµÄ·¢Éú¡£
³öѪʼþ¹ÜÀí
µ±³öѪʼþ·¢Éúʱ£¬¼°Ê±²ÉÈ¡´ëÊ©ÒÔֹѪºÍ¼õÇáÖ¢×´ÖÁ¹ØÖØÒª£¬°üÀ¨Ê¹Óñù·ó¡¢Ñ¹ÆÈ¡¢Ìá¸ß»¼Ö«¡¢Êä×¢ÄýѪÒò×ӵȷ½·¨¡£
Éú»î·½Ê½¹ÜÀí
½øÐÐÊʶȵͳå»÷Ô˶¯£¬±£³Ö¾ùºâÒûʳ£¬±ÜÃâ¸ß·çÏջºÍʹÓÿÉÄܸÉÈÅÄýѪµÄÒ©Îï¡£
¶¨ÆÚ¼à²âÓëµ÷ÕûÖÎÁÆ
¶¨ÆÚ¼ì²âÄýѪ¹¦ÄÜ¡¢ÆÀ¹À¹Ø½Ú½¡¿µ¡¢É¸²é²¢·¢Ö¢£¬¸ù¾Ý²¡Çéµ÷ÕûÌæ´úÒò×ÓÖÎÁÆ·½°¸¡£
ÒÅ´«×Éѯ
»¼Õß¼°Æä¼ÒÍ¥Ó¦½ÓÊÜÒÅ´«×Éѯ£¬Ã÷È·²¡Òò¡¢ÒÅ´«·½Ê½£¬»ñÈ¡ÉúÓý·çÏÕ¹ÜÀí½¨Òé¡£
30%ÒÔÉϵÄѪÓѲ¡»¼Õß²¢Ã»ÓмÒ×åÊ·
ËäÈ»£¬ÑªÓѲ¡ÊÇÒ»ÖÖÒÅ´«ÐÔ¼²²¡£¬µ«²¢²»Òâζ×ÅÕý³£½¡¿µµÄ·òÆ޾Ͳ»»áÉú³ö»¼ÓÐѪÓѲ¡µÄº¢×Ó¡£ÊÂʵÉÏ£¬Í³¼ÆÊý¾Ý½Òʾ£¬³¬¹ý30%µÄѪÓѲ¡»¼Õß²¢ÎÞÒÑÖªµÄ¼Ò×岡ʷ¡£ÕâÊÇΪʲôÄØ£¿Ö÷ÒªÓÐÈýÖÖ¿ÉÄܵÄÔÒò£º
ÒþÐÔÒÅ´«ÌØÐÔ£ºÑªÓѲ¡×ñÑXȾɫÌåÁ¬ËøÒþÐÔÒÅ´«Ä£Ê½¡£Å®ÐÔЯ´øÕßͨ³£½öÓÐÒ»¸öÖ²¡»ùÒò£¬×ÔÉí²»·¢²¡£¬µ«ÔÚÉúÓý¹ý³ÌÖÐÓпÉÄܽ«¸Ã»ùÒò´«µÝ¸ø×ÓÅ®¡£Òò´Ë£¬¼Ò×åÖпÉÄÜ´æÔÚδ±»Ê¶±ðµÄЯ´øÕߣ¬Ö±ÖÁÆäºó´ú³öÏÖÖ¢×´²ÅÏÔ¶³öÒÅ´«Á´¡£
¼Ò×åÊ·¼Ç¼¾ÖÏÞ£ºÓÐʱ£¬¼Ò×岡ʷ¼Ç¼¿ÉÄܲ»È«»ò²»×¼È·¡£ÊÜÏÞÓÚÈÏʶ²»×ã»ò¹ýÍùÒ½ÁÆˮƽ¾ÖÏÞÐÔ£¬¼Ò×åÖпÉÄÜÒÑÓл¼²¡Õ߶øδ±»Ã÷È·Õï¶Ï£¬´Ó¶øÔÚ±íÃæÉϳÊÏÖÎÞ¼Ò×åÊ·µÄÏÖÏó¡£
з¢Í»±ä£º¾¡¹ÜÏà¶Ô½ÏÉÙ¼û£¬µ«ÑªÓѲ¡²¡ÀýÒ²¿ÉÄÜÓÉз¢Í»±äÒýÆð¡£¼´ÔÚ¸¸Ä¸Ë«·½µÄÉúֳϸ°ûÐγɻòÊܾ«ÂÑÐγɡ¢ÅßÌ¥·¢ÓýÔçÆÚ²úÉúµÄ»ùÒòÍ»±ä£¬´«µÝµ½ÁËÏÂÒ»´ú¡£ÕâÖÖÇé¿öÔÚÒÅ´«Æ×ϵÉϱíÏÖΪ¡°Í»È»³öÏÖ¡±£¬Ã»ÓÐÏÈÇ°µÄ¼Ò×廼²¡¼Ç¼¡£
Òò´Ë£¬¼´Ê¹¼Ò×åÖÐδÔø³öÏÖ¹ýѪÓѲ¡²¡Àý£¬¸öÌåÈÔÓпÉÄÜî¾»¼¸Ã²¡¡£¶ÔÓÚÈκβ»Ã÷ÔÒòµÄ³ÖÐøÐÔ»ò·´¸´³öÏֵijöѪ֢״£¬ÈçƤ·ôÓÙѪ¡¢Æµ·±Á÷±ÇѪ¡¢¿ÚÇ»³öѪ£¬ÒÔ¼°¹Ø½ÚÖ×ÕÍÌÛÍ´µÈ£¬¾ùÓ¦Ìá¸ß¾¯Ì裬¼°Ê±¾ÍÒ½¡£
»ùÒòɸ²éÖúÁ¦ÑªÓѲ¡·À¿ØÌáÉýÈË¿Ú½¡¿µËØÖÊ
»ùÒòɸ²éÔÚѪÓѲ¡µÄ·À¿ØÖоßÓв»¿ÉÌæ´úµÄµØλ¡£Ëü²»½öÄÜÓÐЧԤ·ÀѪÓѲ¡»¼¶ùµÄ³öÉú£¬ÖúÁ¦ÔçÆÚÕï¶ÏÓë¸ÉÔ¤£¬»¹ÄܽÒʾÒþÐÔЯ´øÕßµÄÒÅ´«·çÏÕ£¬Ö¸µ¼¸÷ÀàÈËȺ½øÐкÏÀíµÄÉúÓý¹ÜÀí£¬¶ÔÌáÉýÈË¿Ú½¡¿µËØÖÊ¡¢¼õÇáÉç»áÒ½ÁƸºµ£Æðµ½Á˹ؼü×÷Óá£
¶ÔÓÚѪÓѲ¡»¼ÕßÀ´Ëµ£¬Èç¹ûÉúÓýÁËͬÑù»¼ÓÐѪÓѲ¡µÄº¢×Ó£¬½«¶Ô¼ÒÍ¥´øÀ´¸ü³ÁÖصĸºµ£¡£Òò´Ë£¬ÑªÓѲ¡»¼ÕߵļÒÍ¥ÐèÒª½øÐÐרҵµÄÒÅ´«×ÉѯºÍ±ØÒªµÄ»ùÒò¼ì²â£¬ÔÚרҵҽÉúµÄÖ¸µ¼ÏÂÑ¡Ôñ²úÇ°Õï¶Ï»òµÚÈý´ú¸¨ÖúÉúÖ³µÈÊֶΣ¬±ÜÃâÏÂÒ»´ú»¼¶ùµÄ³öÉú¡£
´ËÍ⣬ûÓÐÁÙ´²±íÏֵĽ¡¿µÅ®ÐÔÒ²¿ÉÄÜÊÇѪÓѲ¡Ö²¡»ùÒòµÄЯ´øÕߣ¬¶øËýÃǵĺó´úÒ²´æÔÚ×ÅѪÓѲ¡µÄ»¼²¡·çÏÕ¡£Òò´Ë£¬¼´±ãÊǽ¡¿µÕý³£µÄ·òÆÞ£¬ÔÚ±¸ÔÐÆÚ»òÕßÔÐÔçÆÚ½øÐÐѪÓѲ¡Ïà¹ØµÄ»ùÒòɸ²éÒ²ÊǷdz£ÓÐÒâÒåµÄ£¬Õâ¿ÉÒÔ°ïÖúËûÃÇÁ˽â×ÔÉíµÄÖ²¡»ùÒòЯ´øÇé¿ö£¬ÖªÏþºó´úµÄ»¼²¡·çÏÕ²¢½øÐпÆѧµÄÉúÓý¹ÜÀí£¬´Ó¶ø´ïµ½ÓÅÉúÓÅÓýµÄÄ¿µÄ£¬ÓÐЧ½µµÍѪÓѲ¡µÄ·¢²¡ÂÊ¡£
²Î¿¼ÎÄÏ×
[1] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð×÷×é. (2017). ѪÓѲ¡Õï¶ÏÓëÖÎÁÆÖйúר¼Ò¹²Ê¶(2017Äê°æ). ÖлªÑªÒºÑ§ÔÓÖ¾, 38(5), 364-370.
[2] ÖлªÒ½Ñ§»áѪҺѧ·Ö»áѪ˨ÓëֹѪѧ×é, & ÖйúѪÓѲ¡Ð×÷×é. (2020). ѪÓѲ¡ÖÎÁÆÖйúÖ¸ÄÏ(2020Äê°æ).
[3] Ljung, Rolf,Auerswald, Guenter,Benson, Gary, et al. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients[J].European Journal of Haematology.2019,102(2).
[4] ʯºìËÉ, À¸Ö, ÒüÑÞ, ÍõÓ§, & Íõ´¿. (2016). ¼×ÐÍѪÓѲ¡»ùÒòЯ´øÕß¼ì³ö¼°²úÇ°Õï¶ÏÑо¿. ÖлªÊµÓÃÕï¶ÏÓëÖÎÁÆÔÓÖ¾, 30(4), 3.